CURRENT EPISODE

How to Invest in Biotech

Guest: Patrick rivelli

Family considerations drove several of Patrick Rivelli’s career choices but did not prevent him from having brilliant triumphs. Success as a consultant was followed by success as an executive. This led him to found his first company and to fund another startup. The most eloquent evidence of his achievements was exiting two biotech startups in eleven years. If you are a seasoned biotech investor, I’m sure that grabbed your attention. Patrick was also instrumental in founding MIT Angels of the Bay Area and now leads the life science track at MIT Angels in Boston. Learn More.

Helping angel investors and founders build better technology companies

Angel investor Sal Daher, CFA talks to founders, angels, VCs, scholars of entrepreneurship, attorneys and others from whom you and he can learn more about the ineffable art of building great technology startups. 

A seasoned investor, Sal led the first round of funding in SQZ Biotechnologies and Savran Technologies. He was an early investor in Gelesis and Akili Interactive. Sal represents investors on the board of Savran Technologies.

Sal Daher’s investment syndicate:

Featured Episodes

Click here to view all of our episodes and to search by topic.

Sal_closeup.jpg

Sal’s startup sweetspot

a Biotechnology startup that…

  • has strong patents

  • has technology with multiple applications (platform)

  • has low capital requirements (less than $6 million raised may get to major value inflection point)

  • can attract strong interest from strategic players

ESH_Boston_med.jpg

Invest with us

Early stage investing is a team sport.

To be a successful angel investor in technology startups it is essential to have a strong network that helps source and evaluate investments. This network is also crucial to building strong companies that create enduring value. 

Sal Daher’s investment syndicate allows accredited investors access to a unique dealflow of Boston-based startups and the help of a deep angel network in supporting portfolio companies.